This panel of mutations makes it possible to combine some of these new treatments with conventional chemotherapy. For example, the FLT3 receptor is overexpressed or mutated in 80% or 30% of AML, respectively. Such anomalies have led to the development of targeted therapies using tyrosine kinase ...
religions Article "He Who Enters the Bath-House Utters Two Blessings": On the Evolvement and Decline of an Ancient Jewish Prayer Abraham Ofir Shemesh Israel Heritage Department, Ariel University, Kiryat hamadda P.O.B. 3, Ariel 40700, Israel; avi0603@013.net.il Received: 10 August 2017; ...